| Nov 15 |
Fulcrum Therapeutics Third Quarter 2024 Earnings: US$0.35 loss per share (vs US$0.39 loss in 3Q 2023)
|
| Nov 14 |
Fulcrum Therapeutics Inc (FULC) Q3 2024 Earnings Call Highlights: Strategic Advancements Amidst ...
|
| Nov 14 |
Fulcrum Therapeutics, Inc. (FULC) Q3 2024 Earnings Call Transcript
|
| Nov 13 |
Fulcrum Therapeutics GAAP EPS of -$0.35 beats by $0.05
|
| Nov 13 |
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2024
|
| Nov 13 |
Earnings Scheduled For November 13, 2024
|
| Nov 12 |
Fulcrum Therapeutics to Participate in the Stifel Healthcare Conference
|
| Nov 6 |
Fulcrum Therapeutics to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, November 13, 2024 at 8:00 a.m. ET
|
| Oct 25 |
Fulcrum Before Q3 Earnings: How Should Investors Play the Stock?
|
| Oct 21 |
We're Interested To See How Fulcrum Therapeutics (NASDAQ:FULC) Uses Its Cash Hoard To Grow
|
